Abstract
Obesity is associated with severe metabolic diseases such as type 2 diabetes, insulin resistance, cardiovascular disease and some forms of cancer. The pathophysiology of obesity-induced metabolic diseases has been strongly related to white adipose tissue (WAT) dysfunction through several mechanisms such as fibrosis, apoptosis, inflammation, ER and oxidative stress. However, little is known of whether these processes are also present in brown adipose tissue (BAT) during obesity, and the potential consequences on mitochondrial activity. Here we characterized the BAT of obese and hyperglycemic mice treated with a high-fat diet (HFD) for 20 weeks. The hypertrophic BAT from obese mice showed no signs of fibrosis nor apoptosis, but higher levels of inflammation, ER stress, ROS generation and antioxidant enzyme activity than the lean counterparts. The response was attenuated compared with obesity-induced WAT derangements, which suggests that BAT is more resistant to the obesity-induced insult. In fact, mitochondrial respiration in BAT from obese mice was enhanced, with a 2-fold increase in basal oxygen consumption, through the upregulation of complex III of the electron transport chain and UCP1. Altogether, our results show that obesity is accompanied by an increase in BAT mitochondrial activity, inflammation and oxidative damage.
Recommended citation
Alcalá, Martín; Calderon-Dominguez, María; Bustos, Eduviges [et al.]. Increased inflammation, oxidative stress and mitochondrial respiration in brown adipose tissue from obese mice. Scientific Reports, 2017, vol. 7, 16082, p. 1-12. Disponible en: <https://www.nature.com/articles/s41598-017-16463-6#article-info>. Fecha de acceso: 15 dic. 2019. DOI: 10.1038/s41598-017-16463-6.
Grant agreement number
info:eu-repo/grantAgreement/ES/1PE/SAF2014-56671R
info:eu-repo/grantAgreement/ES/1PE/SAF2013-45887-R
info:eu-repo/grantAgreement/ES/1PE/SAF2014-52223-C2-1-R
info:eu-repo/grantAgreement/ES/1PE/SAF2014-52223-C2-2-R
Note
Tis work was supported by the Ministry of Spain (MINECO) (SAF2013-45887-R to LH, SAF2014-56671R to PR, SAF2014-52223-C2-1-R to DS, and SAF2014-52223-C2-2-R to NC, cofunded by the European Regional Development Fund [ERDF]), the Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) (Grant CB06/03/0001 to DS), the Government of Catalonia (2014SGR465 to DS), and the Fundació La Marató de TV3 to DS. We acknowledge A. Zorzano and D. Sebastián (IRB, Barcelona, Spain) for assistance with the Seahorse.